Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

33 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Molecular pathogenesis of chronic lymphocytic leukemia.
Danilov AV, Danilova OV, Klein AK, Huber BT. Danilov AV, et al. Among authors: danilova ov. Curr Mol Med. 2006 Sep;6(6):665-75. doi: 10.2174/156652406778195008. Curr Mol Med. 2006. PMID: 17022736 Review.
Pericardial involvement by chronic lymphocytic leukemia/small lymphocytic lymphoma.
Danilova OV, Danilov AV. Danilova OV, et al. Blood. 2015 Jul 16;126(3):424. doi: 10.1182/blood-2015-04-641571. Blood. 2015. PMID: 26393248 Free PMC article. No abstract available.
Targeting neddylation effectively antagonizes nuclear factor-κB in chronic lymphocytic leukemia B-cells.
Godbersen JC, Paiva C, Danilova OV, Berger A, Brown JR, Danilov AV. Godbersen JC, et al. Among authors: danilova ov. Leuk Lymphoma. 2015 May;56(5):1566-9. doi: 10.3109/10428194.2014.990901. Leuk Lymphoma. 2015. PMID: 26086969
SYK inhibition thwarts the BAFF - B-cell receptor crosstalk and thereby antagonizes Mcl-1 in chronic lymphocytic leukemia.
Paiva C, Rowland TA, Sreekantham B, Godbersen C, Best SR, Kaur P, Loriaux MM, Spurgeon SEF, Danilova OV, Danilov AV. Paiva C, et al. Among authors: danilova ov. Haematologica. 2017 Nov;102(11):1890-1900. doi: 10.3324/haematol.2017.170571. Epub 2017 Aug 24. Haematologica. 2017. PMID: 28838991 Free PMC article.
Pro-apoptotic TP53 homolog TAp63 is repressed via epigenetic silencing and B-cell receptor signalling in chronic lymphocytic leukaemia.
Humphries LA, Godbersen JC, Danilova OV, Kaur P, Christensen BC, Danilov AV. Humphries LA, et al. Among authors: danilova ov. Br J Haematol. 2013 Dec;163(5):590-602. doi: 10.1111/bjh.12580. Epub 2013 Sep 30. Br J Haematol. 2013. PMID: 24117128 Free PMC article.
Dipeptidyl peptidase 2 apoptosis assay determines the B-cell activation stage and predicts prognosis in chronic lymphocytic leukemia.
Danilov AV, Danilova OV, Brown JR, Rabinowitz A, Klein AK, Huber BT. Danilov AV, et al. Among authors: danilova ov. Exp Hematol. 2010 Dec;38(12):1167-77. doi: 10.1016/j.exphem.2010.08.008. Epub 2010 Sep 24. Exp Hematol. 2010. PMID: 20817072 Free PMC article.
The Nedd8-activating enzyme inhibitor MLN4924 thwarts microenvironment-driven NF-κB activation and induces apoptosis in chronic lymphocytic leukemia B cells.
Godbersen JC, Humphries LA, Danilova OV, Kebbekus PE, Brown JR, Eastman A, Danilov AV. Godbersen JC, et al. Among authors: danilova ov. Clin Cancer Res. 2014 Mar 15;20(6):1576-89. doi: 10.1158/1078-0432.CCR-13-0987. Clin Cancer Res. 2014. PMID: 24634471 Free PMC article.
Cell cycle control and adhesion signaling pathways in the development of metastatic melanoma.
Danilov AV, Danilova OV, Huber BT. Danilov AV, et al. Among authors: danilova ov. Cancer Metastasis Rev. 2008 Dec;27(4):707-14. doi: 10.1007/s10555-008-9159-2. Cancer Metastasis Rev. 2008. PMID: 18496651 Review.
Cyclin-Dependent Kinase-9 Is a Therapeutic Target in MYC-Expressing Diffuse Large B-Cell Lymphoma.
Hashiguchi T, Bruss N, Best S, Lam V, Danilova O, Paiva CJ, Wolf J, Gilbert EW, Okada CY, Kaur P, Drew L, Cidado J, Hurlin P, Danilov AV. Hashiguchi T, et al. Mol Cancer Ther. 2019 Sep;18(9):1520-1532. doi: 10.1158/1535-7163.MCT-18-1023. Epub 2019 Jun 26. Mol Cancer Ther. 2019. PMID: 31243099
Pevonedistat, a Nedd8-activating enzyme inhibitor, sensitizes neoplastic B-cells to death receptor-mediated apoptosis.
Paiva C, Godbersen JC, Rowland T, Danilova OV, Danes C, Berger A, Danilov AV. Paiva C, et al. Among authors: danilova ov. Oncotarget. 2017 Mar 28;8(13):21128-21139. doi: 10.18632/oncotarget.15050. Oncotarget. 2017. PMID: 28177892 Free PMC article.
33 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page